Bayer AG
(OTC: BAYRY)
|
4:59 PM UTC, 07/03/24 | |||
---|---|---|---|---|
Last: $7.05 | Change: +0.15 | %Change: +2.17% | Volume: 431,531 |
Open: | $ 7.02 | Volume: | 431,531 | |
---|---|---|---|---|
High: | $ 7.09 | Yield(%) | 0.31 | |
Low: | $ 7.01 | P/E Ratio (ttm): | n/a | |
Dividend ($): | 0.02 | Market Cap ($): | 27.27B | |
EPS ($) | -0.87 | Shares Out: | 3.93B |
% Price Change (last 4 weeks): | -9.90 |
---|---|
% Price Change (last 13 weeks): | -7.84 |
% Price Change (last 26 weeks): | -26.06 |
% Price Change (last 52 weeks): | -49.64 |
% Price Change (year to date): | -25.27 |
Return on Equity (%): | -8.18 |
---|---|
Return on Assets (%): | -2.30 |
Return on Invested Capital (%): | -2.95 |
Gross Profit Margin (%): | 58.54 |
---|---|
Net Profit Margin (%): | -6.17 |
Operating Profit Margin (%): | 17.65 |
|
|
50-day Moving Average: | $7.47 |
---|---|
200-day Moving Average: | $8.74 |
Avg. Daily Vol. (last 50 days): | 1,288,561 |
Avg. Daily Vol. (last 200 days): | 1,616,799 |
52-wk high: | $14.70 |
52-wk low: | $6.89 |
Bid: | $n/a |
Ask: | $n/a |
Bayer AG engages in the business of life science fields of healthcare and nutrition. It operates through the following segments: Crop Science, Pharmaceuticals, and Consumer Health. The Crop Science segment includes developing, producing, and marketing products in seeds and plant traits, crop protection, digital solutions, and customer services to promote sustainable agriculture. The Pharmaceuticals segment is involved in prescription products especially for cardiology and women’s health; specialty therapeutics in the areas of oncology, hematology, ophthalmology, and cell and gene therapy; diagnostic imaging equipment; and necessary contrast agents. The Consumer Health segment focuses on non-prescription products in the dermatology, nutritional supplements, digestive health, allergy, cough and cold, and pain and cardiovascular risk prevention categories. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.
|
Bayer AG
Kaiser-Wilhelm-Allee 1 Leverkusen NW 51368 Phone: 49.214.30.1 Fax: n/a http://www.bayer.com |
Earnings (1year) ($): | -0.87 |
---|---|
Annual Dividend ($): | 0.02 |
Current P/E Ratio (ttm): | n/a |
Book Value ($): | 9.26 |
Cash Flow ($): | 0.27 |
Price/Earnings (x): | n/a |
---|---|
Price/Sales (x): | 0.71 |
Price/Book (x): | 1.00 |
Price/Cash Flow (x): | 8.31 |
Quick Ratio (x): | 0.79 |
---|---|
Current Ratio (x): | 1.26 |
LT Debt/Equity (x): | 115.94 |
Total Debt/Equity (x): | 136.03 |